Company / CapEx per Share
TENAX THERAPEUTICS, INC. CapEx per Share History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2016
5-year range
$0.00 / $0.01
FY2012-FY2016
Trend
-0.9%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has declined for 3 consecutive years, from $0.01 in FY2013 to $0.00 in FY2016.
Based on SEC 10-K filings.
0.00 in FY2016 with a 3-year CAGR of -69.3%.
Declined from $0.01 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -69.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TENAX THERAPEUTICS, INC.'s capex per share has declined for 3 consecutive years.
- In FY2016, capex per share decreased 0.9% year-over-year.
- Peak capex per share was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | $0.00 | -0.9% |
| FY2015 | $0.00 | -96.1% |
| FY2014 | $0.01 | -25.7% |
| FY2013 | $0.01 | +16.6% |
| FY2012 | $0.01 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026